Moira Blyth
Chapel Allerton Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Moira Blyth.
Nature Neuroscience | 2016
Tarjinder Singh; Mitja I. Kurki; David Curtis; Shaun Purcell; Lucy Crooks; Jeremy McRae; Jaana Suvisaari; Himanshu Chheda; Douglas Blackwood; Gerome Breen; Olli Pietiläinen; Sebastian S. Gerety; Muhammad Ayub; Moira Blyth; Trevor Cole; David A. Collier; Eve L. Coomber; Nicholas John Craddock; Mark J. Daly; John Danesh; Marta DiForti; Alison Foster; Nelson B. Freimer; Daniel H. Geschwind; Mandy Johnstone; Shelagh Joss; G. Kirov; Jarmo Körkkö; Outi Kuismin; Peter Holmans
By analyzing the whole-exome sequences of 4,264 schizophrenia cases, 9,343 controls and 1,077 trios, we identified a genome-wide significant association between rare loss-of-function (LoF) variants in SETD1A and risk for schizophrenia (P = 3.3 × 10−9). We found only two heterozygous LoF variants in 45,376 exomes from individuals without a neuropsychiatric diagnosis, indicating that SETD1A is substantially depleted of LoF variants in the general population. Seven of the ten individuals with schizophrenia carrying SETD1A LoF variants also had learning difficulties. We further identified four SETD1A LoF carriers among 4,281 children with severe developmental disorders and two more carriers in an independent sample of 5,720 Finnish exomes, both with notable neuropsychiatric phenotypes. Together, our observations indicate that LoF variants in SETD1A cause a range of neurodevelopmental disorders, including schizophrenia. Combining these data with previous common variant evidence, we suggest that epigenetic dysregulation, specifically in the histone H3K4 methylation pathway, is an important mechanism in the pathogenesis of schizophrenia.
Nature Genetics | 2015
Nadia A. Akawi; Jeremy McRae; Morad Ansari; Meena Balasubramanian; Moira Blyth; Angela F. Brady; Stephen Clayton; Trevor Cole; Charu Deshpande; Tomas Fitzgerald; Nicola Foulds; Richard Francis; George C. Gabriel; Sebastian S. Gerety; Judith A. Goodship; Emma Hobson; Wendy D Jones; Shelagh Joss; Daniel A. King; Nikolai T. Klena; Ajith Kumar; Melissa Lees; Chris Lelliott; Jenny Lord; Dominic McMullan; Mary O'Regan; Deborah Osio; Virginia Piombo; Elena Prigmore; Diana Rajan
Discovery of most autosomal recessive disease-associated genes has involved analysis of large, often consanguineous multiplex families or small cohorts of unrelated individuals with a well-defined clinical condition. Discovery of new dominant causes of rare, genetically heterogeneous developmental disorders has been revolutionized by exome analysis of large cohorts of phenotypically diverse parent-offspring trios. Here we analyzed 4,125 families with diverse, rare and genetically heterogeneous developmental disorders and identified four new autosomal recessive disorders. These four disorders were identified by integrating Mendelian filtering (selecting probands with rare, biallelic and putatively damaging variants in the same gene) with statistical assessments of (i) the likelihood of sampling the observed genotypes from the general population and (ii) the phenotypic similarity of patients with recessive variants in the same candidate gene. This new paradigm promises to catalyze the discovery of novel recessive disorders, especially those with less consistent or nonspecific clinical presentations and those caused predominantly by compound heterozygous genotypes.
Journal of Medical Genetics | 2016
Annmarie Hempel; Alistair T. Pagnamenta; Moira Blyth; Sahar Mansour; Vivienne McConnell; Ikuyo Kou; Shiro Ikegawa; Yoshinori Tsurusaki; Naomichi Matsumoto; Adriana Lo-Castro; Ghislaine Plessis; Beate Albrecht; Agatino Battaglia; Jenny C. Taylor; Malcolm F. Howard; David A. Keays; Aman Singh Sohal; Susanne J. Kühl; Usha Kini; Alisdair McNeill
Background SOX11 is a transcription factor proposed to play a role in brain development. The relevance of SOX11 to human developmental disorders was suggested by a recent report of SOX11 mutations in two patients with Coffin–Siris syndrome. Here we further investigate the role of SOX11 variants in neurodevelopmental disorders. Methods We used array based comparative genomic hybridisation and trio exome sequencing to identify children with intellectual disability who have deletions or de novo point mutations disrupting SOX11. The pathogenicity of the SOX11 mutations was assessed using an in vitro gene expression reporter system. Loss-of-function experiments were performed in xenopus by knockdown of Sox11 expression. Results We identified seven individuals with chromosome 2p25 deletions involving SOX11. Trio exome sequencing identified three de novo SOX11 variants, two missense (p.K50N; p.P120H) and one nonsense (p.C29*). The biological consequences of the missense mutations were assessed using an in vitro gene expression system. These individuals had microcephaly, developmental delay and shared dysmorphic features compatible with mild Coffin–Siris syndrome. To further investigate the function of SOX11, we knocked down the orthologous gene in xenopus. Morphants had significant reduction in head size compared with controls. This suggests that SOX11 loss of function can be associated with microcephaly. Conclusions We thus propose that SOX11 deletion or mutation can present with a Coffin–Siris phenotype.
European Journal of Medical Genetics | 2015
Florence Petit; Ghislaine Plessis; Matthieu Decamp; Jean-Marie Cuisset; Moira Blyth; Maria Pendlebury; Joris Andrieux
Here we report three patients affected with neurodevelopmental disorders and harbouring 21q21 deletions involving NCAM2 gene. NCAM (Neural Cell Adhesion Molecule) proteins are involved in axonal migration, synaptic formation and plasticity. Poor axonal growth and fasciculation is observed in animal models deficient for NCAM2. Moreover, this gene has been proposed as a candidate for autism, based on genome-wide association studies. In this report, we provide a comprehensive molecular and phenotypical characterisation of three deletion cases giving additional clues for the involvement of NCAM2 in neurodevelopment.
Journal of Medical Genetics | 2015
Moira Blyth; Viv Maloney; Sarah J. Beal; Morag N. Collinson; Shuwen Huang; John A. Crolla; I. Karen Temple; Diana Baralle
Background Pallister-Killian syndrome is a rare, sporadic condition caused by mosaic tetrasomy of the short arm of chromosome 12 (12p). The main features are intellectual disability, seizures, dysmorphic features and a variety of congenital malformations. Most available information comes from individual case reports. We report the results of a British study into Pallister-Killian syndrome, which is the first to provide comprehensive data on a population-based sample. Method A detailed phenotypical study was carried out in Great Britain. All individuals with Pallister-Killian syndrome were eligible to participate. Each participant underwent a structured history, developmental assessment and clinical examination. Buccal mucosal samples were analysed by interphase fluorescence in situ hybridization (FISH) and blood samples by array comparative genomic hybridization (CGH). Genotype-phenotype correlations were sought in these tissues and existing skin biopsy reports. Results Twenty-two patients with Pallister-Killian syndrome, ranging from 4 months to 31 years were recruited and comprehensive data on each obtained. The birth incidence was 5.1 per million live births. Array CGH only suggested the diagnosis in 15.8% but buccal FISH could have made the diagnosis in 75.0%. There was no genotype-phenotype correlation in any of the tissues studied. This study shows that the high birth weights and profound intellectual disability classically described in Pallister-Killian syndrome are not universal. Mild or moderate intellectual disability was present in 27.6% of this cohort and all birth weights were within 2.67SD of the mean. New features which have not previously been recognised as part of Pallister-Killian syndrome include anhydrosis/ hypohydrosis and episodic hyperventilation, suggesting involvement of the autonomic system.
American Journal of Medical Genetics Part A | 2014
David J. Bunyan; Emma-Jane Taylor; Vivienne Maloney; Moira Blyth
Léri–Weill dyschondrosteosis is caused by heterozygous mutations in SHOX or its flanking sequences, including whole or partial gene deletions, point mutations within the coding sequence, and deletions of downstream regulatory elements. The same mutations when biallelic cause the more severe Langer Mesomelic dysplasia. Here, we report on a consanguineous family with a novel deletion downstream of SHOX in which homozygously deleted individuals have a phenotype intermediate between Léri–Weill dyschondrosteosis and Langer Mesomelic dysplasia while heterozygously deleted individuals are mostly asymptomatic. The deleted region is distal to all previously described 3′ deletions, suggesting the presence of an additional regulatory element, deletions of which have a milder, variable phenotypic effect.
Clinical Dysmorphology | 2016
Mark James Hamilton; Ruth Newbury-Ecob; Muriel Holder-Espinasse; Shu Yau; Suzanne Lillis; Jane A. Hurst; Emma Clement; William Reardon; Shelagh Joss; Emma Hobson; Moira Blyth; Maryam Al-shehhi; Sally Ann Lynch; Mohnish Suri
Rubinstein–Taybi syndrome (RTS) is an autosomal dominant neurodevelopmental disorder characterized by growth deficiency, broad thumbs and great toes, intellectual disability and characteristic craniofacial appearance. Mutations in CREBBP account for around 55% of cases, with a further 8% attributed to the paralogous gene EP300. Comparatively few reports exist describing the phenotype of Rubinstein–Taybi because of EP300 mutations. Clinical and genetic data were obtained from nine patients from the UK and Ireland with pathogenic EP300 mutations, identified either by targeted testing or by exome sequencing. All patients had mild or moderate intellectual impairment. Behavioural or social difficulties were noted in eight patients, including three with autistic spectrum disorders. Typical dysmorphic features of Rubinstein–Taybi were only variably present. Additional observations include maternal pre-eclampsia (2/9), syndactyly (3/9), feeding or swallowing issues (3/9), delayed bone age (2/9) and scoliosis (2/9). Six patients had truncating mutations in EP300, with pathogenic missense mutations identified in the remaining three. The findings support previous observations that microcephaly, maternal pre-eclampsia, mild growth restriction and a mild to moderate intellectual disability are key pointers to the diagnosis of EP300-related RTS. Variability in the presence of typical facial features of Rubinstein–Taybi further highlights clinical heterogeneity, particularly among patients identified by exome sequencing. Features that overlap with Floating–Harbor syndrome, including craniofacial dysmorphism and delayed osseous maturation, were observed in three patients. Previous reports have only described mutations predicted to cause haploinsufficiency of EP300, whereas this cohort includes the first described pathogenic missense mutations in EP300.
Journal of Neurology, Neurosurgery, and Psychiatry | 2010
Moira Blyth; Michela Raponi; Rebecca Treacy; F. Lucy Raymond; John R.W. Yates; Diana Baralle
Tuberous sclerosis (TS) is an autosomal dominant disorder with variable expression, which causes epilepsy, mental retardation and hamartomas in many organ systems. TS is caused by mutations in two genes, TSC1 on 9q34 and TSC2 on 16p13.3. Mutations can be detected in approximately 85% of patients who meet the published consensus clinical diagnostic criteria.1–3 The remainder probably have mutations in intronic or promoter regions, which are not routinely screened, or are mosaic for the condition. Genotype–phenotype correlations have been slow to emerge in this disorder but TSC2 mutations tend to be associated with more severe disease than TSC1 mutations.2 3 Most TSC1 mutations are single base substitutions or small insertions/deletions, and cause protein truncation. A small number are putative splice site mutations but the effects on the proteins produced have not been studied in detail. Splicing is the process in which introns are excised from the RNA and exons joined together to form messenger RNA transcript, which is translated into the protein. We present a family with an unusually mild phenotype caused by a novel TSC1 splice site (SS) mutation. This proband was admitted to hospital following an episode of unconsciousness with cyanosis at 4.5 months of age. Cranial CT scan showed …
European Journal of Human Genetics | 2016
Jeroen Breckpot; Britt-Marie Anderlid; Yasemin Alanay; Moira Blyth; Afane Brahimi; Bénédicte Duban-Bedu; Odile Gozé; Helen V. Firth; Mustafa Cengiz Yakicier; Greet Hens; Maissa Rayyan; Eric Legius; Joris Vermeesch; Koen Devriendt
We report on seven novel patients with a submicroscopic 22q12 deletion. The common phenotype constitutes a contiguous gene deletion syndrome on chromosome 22q12.1q12.2, featuring NF2-related schwannoma of the vestibular nerve, corpus callosum agenesis and palatal defects. Combining our results with the literature, eight patients are recorded with palatal defects in association with haploinsufficiency of 22q12.1, including the MN1 gene. These observations, together with the mouse expression data and the finding of craniofacial malformations including cleft palate in a Mn1-knockout mouse model, suggest that this gene is a candidate gene for cleft palate in humans.
American Journal of Medical Genetics Part A | 2016
Madeleine Tooley; Danielle C. Lynch; Francois P. Bernier; Jillian S. Parboosingh; Elizabeth J. Bhoj; Elaine H. Zackai; Alistair Calder; Nobue Itasaki; Emma Wakeling; Richard H. Scott; Melissa Lees; Jill Clayton-Smith; Moira Blyth; Jenny Morton; Debbie Shears; Usha Kini; Tessa Homfray; Angus John Clarke; Angela Barnicoat; Colin Wallis; Rebecca Hewitson; Amaka C. Offiah; Michael Saunders; Simon Langton-Hewer; Tom Hilliard; Peter Davis; Sarah F. Smithson
Cerebro–Costo–Mandibular syndrome (CCMS) is a rare autosomal dominant condition comprising branchial arch‐derivative malformations with striking rib‐gaps. Affected patients often have respiratory difficulties, associated with upper airway obstruction, reduced thoracic capacity, and scoliosis. We describe a series of 12 sporadic and 4 familial patients including 13 infants/children and 3 adults. Severe micrognathia and reduced numbers of ribs with gaps are consistent findings. Cleft palate, feeding difficulties, respiratory distress, tracheostomy requirement, and scoliosis are common. Additional malformations such as horseshoe kidney, hypospadias, and septal heart defect may occur. Microcephaly and significant developmental delay are present in a small minority of patients. Key radiological findings are of a narrow thorax, multiple posterior rib gaps and abnormal costo‐transverse articulation. A novel finding in 2 patients is bilateral accessory ossicles arising from the hyoid bone. Recently, specific mutations in SNRPB, which encodes components of the major spliceosome, have been found to cause CCMS. These mutations cluster in an alternatively spliced regulatory exon and result in altered SNRPB expression. DNA was available from 14 patients and SNRPB mutations were identified in 12 (4 previously reported). Eleven had recurrent mutations previously described in patients with CCMS and one had a novel mutation in the alternative exon. These results confirm the specificity of SNRPB mutations in CCMS and provide further evidence for the role of spliceosomal proteins in craniofacial and thoracic development.